
Sign up to save your podcasts
Or


Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
CME information and select publications here.
By Dr. Neil Love4.9
5656 ratings
Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
CME information and select publications here.

134 Listeners

327 Listeners

502 Listeners

67 Listeners

31 Listeners

77 Listeners

15 Listeners

17 Listeners

12 Listeners

0 Listeners

121 Listeners

59 Listeners

3,377 Listeners

206 Listeners

48 Listeners

23 Listeners

364 Listeners

197 Listeners

46 Listeners

0 Listeners